EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Opening SCID newborn screening for novel exon genetic variants through whole-exome sequencing in China

Xiao Yang, JianHu He, Wei Peng, Sheng Zheng, Ning Ma, YuHan Chen, Jian Shen, XiangYong Kong

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiao Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pediatrics, the Chinese PLA General Hospital, Beijing, China; Institute of Pediatrics, the Seventh Medical Center of PLA General Hospital,…. Hauptthemen laut MEDLINE: Severe Combined Immunodeficiency, Exome Sequencing, Neonatal Screening. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Severe combined immunodeficiency (SCID) is the most fatal form of inherited primary immunodeficiency disease. Known molecular defect mutations occur in most children with SCID. METHODS: Herein, we report Adenosine Deaminase-SCID (ADA-SCID) using whole-exome sequencing (WES), explore exome mutational landscape and significance for 17 SCID samples, and verify the mutated exon genes using the Gene Expression Omnibus (GEO) datasets. A total of 250 patients, who were hospitalized at the Neonatal Intensive Care Unit (NICU) of The Seventh Medical Center of the PLA General Hospital for 3 years (from 2017 to 2020), were screened for SCID. We collected mutated genes from the WES data of 17 SCID children. GSE609 and GSE99176 cohorts were used to identify the expressions of mutated exon genes and molecular features in SCID. Gene set variation analyses (GSVA) and correlation analyses were performed. RESULTS: The detection rate with approximately 6.8 % (17/250) of SCID is high in the NICU. A total of 16 genes were identified among 17 SCID samples, of which the Top 2 genes (MUC6 and RP11-683L23.1) might be crucial in the progression of SCID with 94 % mutation frequency. Furthermore, CNN2 and SCGB1C1 had significant co-mutations and may cooperate to affect SCID development. Importantly, the phylogenetic tree classification results of 17 SCID samples are more correlated to MUC6 with the most significant mutations. Expression profiles of seven mutated genes and five mutated genes were documented in GSE609 and GSE99176 cohorts based on microarray, respectively. Several immune-related pathways were significantly enriched, and Foxd4, differing from the other four mutated genes, was inversely correlated with the GSVA-enriched pathway. CONCLUSION: Due to its high detection rate (6.8%) and fatality rate (100%), the inclusion of SCID in newborn screening (NBS) is urgent for children in China. The WES successfully identified several common exonic variants (e.g., MUC6) and depicted the feature of mutations and evolution, which will help develop new diagnostic methods for SCID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Combined ImmunodeficiencyExome SequencingNeonatal ScreeningHumansInfant, NewbornChinaMaleFemaleExonsMutationAdenosine Deaminase

Stichwörter der Autor:innen

Adenosine deaminaseExon genetic variantsMUC6Severe combined immunodeficiencyWhole-exome sequencing

Substanzen

Adenosine Deaminase

Autor:innen und Institutionen

  • Faculty of Pediatrics, the Chinese PLA General Hospital, Beijing, China; Institute of Pediatrics, the Seventh Medical Center of PLA General Hospital, Beijing, China; National Engineering Laboratory for Birth defects pre…
  • Department of Information, Women's Hospital School of Medicine Zhejiang University, Zhejiang, China.
  • ShangHai Z&S Biotechnology Company, Shanghai, China.
  • Department of Gynecology and Obstetrics, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200003, China. Electronic address: sj11002@rjh.com.cn.

Zitieren

APA

Yang, X., He, J., Peng, W., Zheng, S., Ma, N., Chen, Y., Shen, J., & Kong, X. (2024). Opening SCID newborn screening for novel exon genetic variants through whole-exome sequencing in China. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112402

Vancouver

Yang X, He J, Peng W, Zheng S, Ma N, Chen Y, et al. Opening SCID newborn screening for novel exon genetic variants through whole-exome sequencing in China. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112402

BibTeX
@article{Yang2024,
  author = {Yang, Xiao and He, JianHu and Peng, Wei and Zheng, Sheng and Ma, Ning and Chen, YuHan and Shen, Jian and Kong, XiangYong},
  title = {Opening SCID newborn screening for novel exon genetic variants through whole-exome sequencing in China},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112402}
}
Kostenlos starten →